[Ip-health] MSF announces new Executive Director of the Access Campaign
joanna.l.keenan at gmail.com
Thu May 31 06:59:52 PDT 2012
*MSF announces new Executive Director of the Access Campaign*
*Dr Manica Balasegaram to take up position from mid-August*
*Geneva**, 31 May* *2011*– After six successful years leading Médecins Sans
Frontières’ (MSF) Access Campaign, Dr Tido von Schoen-Angerer will today
stand down from his position as Executive Director.
Dr von Schoen-Angerer will be succeeded by Dr Manica Balasegaram. Dr
Balasegaram takes up his new role as MSF Access Campaign Executive Director
in mid-August and will be based in Geneva, Switzerland.
Dr von Schoen-Angerer stepped into the role as Executive Director in
September 2006 and leaves after 14 years with MSF, where he worked in
different field and headquarters positions, from field doctor to Director
Dr Balasegaram is currently the Head of the Leishmaniasis Clinical Program
for Drugs for Neglected Diseases *initiative *(DND*i*), and brings to the
role extensive experience in tropical medicine including malaria, sleeping
sickness, and visceral leishmaniasis. He also has previous MSF experience
as Head of the Manson Unit, a London-based medical research and
implementation arm of MSF, and has held a board position with MSF
Switzerland. Dr Balasegaram has also worked in MSF medical projects in
Uganda, Sudan, Republic of Congo, Ethiopia, India and Bangladesh.
“On behalf of MSF, I’d like to thank Dr von Schoen-Angerer for his strong
leadership of the Access Campaign as well as multiple other contributions
to MSF over the last 14 years”, said Dr Unni Karunakara, MSF International
“I am delighted that Dr Manica Balasegaram will take over as leader of the
Access Campaign and am confident that he has the experience to successfully
build on past successes to increase access to essential medicines and
medical tools”, Dr Karunakara said.
With Dr von Schoen-Angerer’s departure at the end of May, Access Campaign
Deputy Director Daniel Berman will fill the role of interim Executive
Director until Dr Balasegaram starts in his new role.
- ends -
Médecins Sans Frontières - Access Campaign
More information about the Ip-health